RG
DSCI

Redmile Group’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Redmile Group’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-600,677
Closed -$6.94M – 69
2014
Q2 		$6.94M Buy
600,677
+2,600
+0.4% +$26.7K 0.84% 38
2014
Q1 		$7.58M Buy
+598,077
New +$7.73M 0.91% 40

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Redmile Group's DSCI Position: Q3 2014 in Review

Redmile Group sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 600,677 shares — an estimated $6.94M sold.

Redmile Group first reported a position in DSCI in Q1 2014 and held it in 2 quarters. The position peaked at $7.58M in Q1 2014. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Redmile Group reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Redmile Group sold 600,677 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $6.94M.
  • Redmile Group first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 2 quarters.
  • Redmile Group's Derma Sciences, Inc. Common Stock (DE) position peaked at $7.58M in Q1 2014.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Redmile Group's 13F filing for Q3 2014, filed 14 Nov 2014.